Literature DB >> 15175824

Chronic hepatitis B virus infection and dyslipidemia.

Ta-Chen Su1, Yuan-Teh Lee, Tsun-Jen Cheng, Hsu-Ping Chien, Jung-Der Wang.   

Abstract

BACKGROUND AND
PURPOSE: The association of chronic hepatitis B virus (HBV) infection and decreased levels of high-density lipoprotein cholesterol (HDL-C) has been well documented. However, the relationship between dyslipidemia and asymptomatic chronic HBV infection is still unclear.
METHODS: In 1997, 1330 medical center employees (405 men and 925 women) were recruited to evaluate the effects of chronic HBV infection on serum lipid profile, including total cholesterol (TC), HDL-C, low-density lipoprotein cholesterol, and triglycerides (TG). Among these patients, 195 were found to have chronic HBV infection and 35 (17.9%) of them were found to have elevated alanine aminotransferase (ALT). Multiple linear regression analyses were used to evaluate the effects of chronic HBV infection on serum lipids.
RESULTS: The most significant finding was that levels of TC and HDL-C were decreased by 5.8 and 2.7 mg/dL respectively, among patients with asymptomatic chronic HBV infection (serum ALT < 40 U/L). After controlling for other determinants, male gender, old age, higher body mass index (BMI) and waist-to-hip ratio, current smoking, and hepatitis B surface antigen-negative status with ALT > or = 40 U/L were associated with lower serum HDL-C and higher TG levels. However, moderate to heavy alcohol drinking, physically active lifestyle, and lower BMI were associated with higher levels of HDL-C.
CONCLUSIONS: Asymptomatic chronic HBV infection was associated with lower serum levels of TC and HDL-C. Elevation of ALT was also an indicator of lower levels of HDL-C in patients with chronic hepatitis B and lower serum HDL-C and higher TG levels in patients without HBV infection. These findings also indicated the need to monitor the risk of atherosclerotic diseases in patients with asymptomatic chronic HBV infection, especially those with lower HDL-C levels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175824

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  19 in total

Review 1.  Pre-S2 Mutant-Induced Mammalian Target of Rapamycin Signal Pathways as Potential Therapeutic Targets for Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Woei-Cherng Shyu; Long-Bin Jeng; Ih-Jen Su
Journal:  Cell Transplant       Date:  2017-02-14       Impact factor: 4.064

Review 2.  Association between hepatitis B and metabolic syndrome: Current state of the art.

Authors:  Peter Jarcuska; Sylvia Drazilova; Jan Fedacko; Daniel Pella; Martin Janicko
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  Activation of ATP citrate lyase by mTOR signal induces disturbed lipid metabolism in hepatitis B virus pre-S2 mutant tumorigenesis.

Authors:  Chiao-Fang Teng; Han-Chieh Wu; Wen-Chuan Hsieh; Hung-Wen Tsai; Ih-Jen Su
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

4.  Association of brain-type natriuretic protein and cardiac troponin I with incipient cardiovascular disease in chimpanzees (Pan troglodytes).

Authors:  John J Ely; Tony Zavaskis; Michael L Lammey; Meg M Sleeper; D Rick Lee
Journal:  Comp Med       Date:  2011-04       Impact factor: 0.982

5.  Association between chronic hepatitis B infection and metabolic syndrome.

Authors:  Xiaohui Zhao; Drishti Shah; Usha Sambamoorthi
Journal:  J Diabetes Metab Disord       Date:  2018-10-27

6.  The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection.

Authors:  Ashraf Mohamadkhani; Kourosh Sayemiri; Reza Ghanbari; Elham Elahi; Hossein Poustchi; Ghodratollah Montazeri
Journal:  Virol J       Date:  2010-09-14       Impact factor: 4.099

Review 7.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

8.  Association between Hepatitis B Surface Antigen Seropositivity and Metabolic Syndrome.

Authors:  Tae-Heum Chung; Moon-Chan Kim; Chang-Sup Kim
Journal:  Korean J Fam Med       Date:  2014-03-24

9.  Association between hepatitis B virus infection and metabolic syndrome: a retrospective cohort study in Shanghai, China.

Authors:  Yanbing Zhou; Yan Cui; Haiju Deng; Jinming Yu
Journal:  BMC Public Health       Date:  2014-05-28       Impact factor: 3.295

10.  Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome in Korean adult men.

Authors:  Ja Sung Choi; Ki Jun Han; Sangheun Lee; Song Wook Chun; Dae Jung Kim; Hyeon Chang Kim; Hee Man Kim
Journal:  J Epidemiol       Date:  2014-10-04       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.